AU2020903909A0 - Peptide-based delivery of agents - Google Patents

Peptide-based delivery of agents

Info

Publication number
AU2020903909A0
AU2020903909A0 AU2020903909A AU2020903909A AU2020903909A0 AU 2020903909 A0 AU2020903909 A0 AU 2020903909A0 AU 2020903909 A AU2020903909 A AU 2020903909A AU 2020903909 A AU2020903909 A AU 2020903909A AU 2020903909 A0 AU2020903909 A0 AU 2020903909A0
Authority
AU
Australia
Prior art keywords
peptide
agents
based delivery
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020903909A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Florey Institute of Neuroscience and Mental Health
Original Assignee
Florey Institute of Neuroscience and Mental Health
Filing date
Publication date
Application filed by Florey Institute of Neuroscience and Mental Health filed Critical Florey Institute of Neuroscience and Mental Health
Publication of AU2020903909A0 publication Critical patent/AU2020903909A0/en
Priority to PCT/AU2021/051255 priority Critical patent/WO2022087669A1/en
Priority to US18/034,526 priority patent/US20230399378A1/en
Priority to EP21884158.3A priority patent/EP4237010A1/en
Priority to AU2021368859A priority patent/AU2021368859A1/en
Priority to AU2023233145A priority patent/AU2023233145A1/en
Abandoned legal-status Critical Current

Links

AU2020903909A 2020-10-28 2020-10-28 Peptide-based delivery of agents Abandoned AU2020903909A0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PCT/AU2021/051255 WO2022087669A1 (en) 2020-10-28 2021-10-28 Peptide-based delivery of agents
US18/034,526 US20230399378A1 (en) 2020-10-28 2021-10-28 Peptide-based delivery of agents
EP21884158.3A EP4237010A1 (en) 2020-10-28 2021-10-28 Peptide-based delivery of agents
AU2021368859A AU2021368859A1 (en) 2020-10-28 2021-10-28 Peptide-based delivery of agents
AU2023233145A AU2023233145A1 (en) 2020-10-28 2023-09-21 Peptide-based delivery of agents

Publications (1)

Publication Number Publication Date
AU2020903909A0 true AU2020903909A0 (en) 2020-11-12

Family

ID=

Similar Documents

Publication Publication Date Title
EP3914252A4 (en) Pharmaceutical compositions of nilotinib
EP3840730A4 (en) Compositions for the delivery of therapeutic agents and methods of use and making thereof
EP3820885A4 (en) Methods and compositions for delivery of agents across the blood-brain barrier
EP4097138A4 (en) Asgpr-binding compounds for the degradation of extracellular proteins
EP3813853A4 (en) Compositions for drug delivery and methods of use thereof
EP4058190A4 (en) Compositions and methods for controlled delivery and protection of therapeutic agents
EP3937905A4 (en) Rinse-off compositions and uses thereof for delivery of active agents
EP4098258A4 (en) Pharmaceutical use of ketoamide-based compound
EP3908251A4 (en) Pharmaceutical delivery compositions and uses thereof
EP3768829A4 (en) Formulations for improving the delivery of hydrophobic agents
EP4037740A4 (en) Acoustic nebuliser for delivery of active agents
EP3509573A4 (en) Pharmaceutical compositions for delivery of peptide
EP4132511A4 (en) Pharmaceutical compositions comprising meloxicam
EP3958889A4 (en) Collagen peptide-based medicament compositions and devices and methods of production and use thereof
EP3777893A4 (en) Use of bis-iminobiotin compound for drug delivery purposes
EP4054527A4 (en) Topical delivery of tofacitinib using ionic liquid
EP4006057A4 (en) Complex for intracellular delivery of molecules
EP3963085A4 (en) Inhibitors of rna-binding proteins, compositions thereof, and therapeutic uses thereof
AU2020903909A0 (en) Peptide-based delivery of agents
AU2019904023A0 (en) Peptide-based delivery of agents
EP4103237A4 (en) Methods for improved delivery of therapeutic agents
EP4079305A4 (en) Application of compound in drug preparation
EP4057941A4 (en) Stable formulations of silk-derived protein
EP4127136A4 (en) Use of exosome-based delivery of nf-kb inhibitors
EP3999529A4 (en) Hemoglobin-based therapeutic agents